|
1
|
Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases.
|
Ann Surg
|
2009
|
2.11
|
|
2
|
Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
|
Ann Surg Oncol
|
2006
|
1.87
|
|
3
|
Biweekly chemotherapy with oxaliplatin, irinotecan, infusional Fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer.
|
J Clin Oncol
|
2002
|
1.27
|
|
4
|
Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations.
|
Genes Chromosomes Cancer
|
2002
|
1.09
|
|
5
|
Supportive care and not only palliative care in the route of cancer patients.
|
Support Care Cancer
|
2012
|
0.88
|
|
6
|
Dedicated supportive care team at the oncology unit: a model of simultaneous care for cancer patients.
|
Support Care Cancer
|
2014
|
0.88
|
|
7
|
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen.
|
Clin Colorectal Cancer
|
2011
|
0.80
|